A new executive order takes decisive steps to improve the safety and oversight of biological research, especially dangerous gain-of-function experiments. It halts U.S. funding for risky research conducted abroad in countries lacking robust safety standards and mandates stronger domestic controls—even for non-federally funded projects. The order calls for updated oversight frameworks, transparency measures, and strict enforcement terms to prevent public health and national security risks. The goal: safeguard innovation while ensuring accountability and biosecurity.
Format: |
|
Topics: | |
Website: | Visit Publisher Website |
Publisher: | The White House |
Published: | May 5, 2025 |
License: | Public Domain |